Inhibition of angiogenesis by synthetic matrix metalloprotease i

Details Inhibition of angiogenesis by synthetic matrix metalloprotease i Inhibition of angiogenesis by synthetic matrix metalloprotease i

1992-01-07

1993-12-07

Springer, David B.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

548495, C07D20920, A61K 31405

Patent

active

052683842

ABSTRACT:
Synthetic mammalian matrix metalloprotease inhibitors are useful in controlling angiogenesis. These compounds are thus useful in controlling the growth of tumors and in controlling neovascular glaucomas.

REFERENCES:
patent: 4291048 (1981-09-01), Gold
patent: 4558034 (1985-12-01), Galardy et al.
patent: 4599361 (1986-07-01), Dickens et al.
patent: 4681894 (1987-07-01), Murray et al.
patent: 4698342 (1987-10-01), Crosby
patent: 4743587 (1988-05-01), Dickens et al.
patent: 4918105 (1990-04-01), Cartwright
patent: 4943587 (1990-07-01), Cetenko et al.
Mullins et al., Biochim. Biophys. Acta (1983) 695:177-214.
Reich et al., Cancer Res. (1988) 48:3307-3312.
Nishino et al., Biochemistry (1979) 18:4340-4347.
Nishino et al., Biochemistry (1978) 17:2846-2850.

Affiliated with

Also associated with

Rating

Inhibition of angiogenesis by synthetic matrix metalloprotease i does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Inhibition of angiogenesis by synthetic matrix metalloprotease i, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibition of angiogenesis by synthetic matrix metalloprotease i will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2016009